A detailed history of Geode Capital Management, LLC transactions in Dyadic International Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 224,391 shares of DYAI stock, worth $347,806. This represents 0.0% of its overall portfolio holdings.

Number of Shares
224,391
Previous 222,696 0.76%
Holding current value
$347,806
Previous $358,000 4.47%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.29 - $1.67 $2,186 - $2,830
1,695 Added 0.76%
224,391 $374,000
Q3 2023

Nov 13, 2023

BUY
$1.71 - $2.08 $14,514 - $17,655
8,488 Added 3.96%
222,696 $427,000
Q4 2022

Feb 13, 2023

BUY
$1.18 - $2.29 $4,711 - $9,143
3,993 Added 1.9%
214,208 $263,000
Q2 2022

Aug 12, 2022

BUY
$1.85 - $3.22 $1,687 - $2,936
912 Added 0.44%
210,215 $641,000
Q1 2022

May 13, 2022

SELL
$3.01 - $4.81 $373 - $596
-124 Reduced 0.06%
209,303 $630,000
Q3 2021

Nov 12, 2021

BUY
$3.3 - $6.49 $106,098 - $208,659
32,151 Added 18.14%
209,427 $1.16 Million
Q2 2021

Aug 13, 2021

SELL
$3.35 - $5.67 $512,295 - $867,079
-152,924 Reduced 46.31%
177,276 $636,000
Q1 2021

May 12, 2021

BUY
$4.75 - $6.87 $128,288 - $185,544
27,008 Added 8.91%
330,200 $1.81 Million
Q4 2020

Feb 12, 2021

BUY
$5.35 - $7.77 $30,553 - $44,374
5,711 Added 1.92%
303,192 $1.63 Million
Q3 2020

Nov 13, 2020

BUY
$7.22 - $9.11 $35,255 - $44,484
4,883 Added 1.67%
297,481 $2.25 Million
Q2 2020

Aug 13, 2020

BUY
$4.93 - $10.26 $577,376 - $1.2 Million
117,115 Added 66.74%
292,598 $2.53 Million
Q4 2019

Feb 13, 2020

BUY
$5.02 - $6.66 $13,669 - $18,135
2,723 Added 1.58%
175,483 $909,000
Q2 2019

Aug 14, 2019

BUY
$3.15 - $6.95 $544,194 - $1.2 Million
172,760 New
172,760 $1.08 Million

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $44.1M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.